ShockWave Medical, Inc. ( SWAV) Stock. Should you Buy or Sell? $ 287.14
-6.06 (-2.16 %)
ShockWave Medical, Inc. Analysis
Updated on 10-09-2022| Symbol | SWAV |
| Price | $287.14 |
| Beta | 1.235 |
| Volume Avg. | $618.66 thousand |
| Market Cap | $10.32 B |
| 52 Week Range | $113.36 - $314.9 |
ShockWave Medical, Inc. opened the day at $287.14 which is -2.16 % on yesterday's close. ShockWave Medical, Inc. has a 52 week high of $314.9 and 52 week low of $113.36, which is a difference of $201.54. We like to see positive, upward trending shares, preferably with momentum. Market capitalization is $10.32 B and total net profit is $237146000 which means the company is trading at 43.50 times profit to market capitalization. Theoretically, if you were to buy ShockWave Medical, Inc. for $10.32 B, it would take 15 years to get your money back. ShockWave Medical, Inc. are in the Medical Devices space which will have a sweet spot and industry standard for net profit multiples.
Price Chart
Financials
ShockWave Medical, Inc. Stock Forecast - Is ShockWave Medical, Inc. a Buy or Sell?
| DCF Score | Strong Buy | |
| ROE Score | Neutral | |
| ROA Score | Neutral | |
| DE Score | Neutral | |
| PE Score | Strong Buy | |
| PB Score | Strong Buy | |
| Overall Recommendation | Buy |
Growth and Value
| PE Ratio | 191.427 |
| Dividend Yiel | 0.000 |
| Net Profit Margin | 0.151 |
Valuing ShockWave Medical, Inc.
| Price Book Value Ratio | 33.721 | Price To Book Ratio | 33.721 |
| Price To Sales Ratio | 28.283 | Price Earnings Ratio | 187.133 |
How liquid is ShockWave Medical, Inc.
| Current Ratio | 5.317 |
| Quick Ratio | 4.300 |
Debt
| Debt Ratio | 0.269 | Debt Equity Ratio | 0.367 |
| Long Term Debt To Capitalization | 0.099 | Total Debt To Capitalization | 0.134 |
Latest news about ShockWave Medical, Inc.
Here we discuss ShockWave Medical (SWAV), CheckCap (CHEK) and Biosig Technologies (BSGM) that have the potential to outperform their industry going forward.
Shockwave Medical (SWAV) reported earnings 30 days ago. What's next for the stock?
They're both soaring thanks to a handful of recent catalysts.
We have narrowed our search to five large-cap momentum stocks that have solid upside left for September. These are: SWAV, PCTY, DINO, MPC and ULTA.
SANTA CLARA, Calif., Aug. 31, 2022 (GLOBE NEWSWIRE) -- In a release issued under the same headline on August 26, 2022, by Shockwave Medical, Inc. (NASDAQ: SWAV), please note that the fireside chat time for the Wells Fargo Healthcare Conference has been updated. The correct presentation time is 9:10 am Eastern Time. The details for the Morgan Stanley Healthcare Conference remain the same.
About ShockWave Medical, Inc.
Description :
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease (PAD); C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee PAD. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.
